KRISTI STEINERT: Open Payments
NPI 1346213915 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 53 payments from 12 companies in 2025. Trend: 2023 $1,224 · 2024 $1,567 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 11 | $195 |
| LEO Pharma Inc. | 10 | $190 |
| Novartis Pharmaceuticals Corporation | 7 | $122 |
| ABBVIE INC. | 5 | $112 |
| Lilly USA, LLC | 4 | $82 |
| PFIZER INC. | 4 | $80 |
| Galderma Laboratories, L.P. | 3 | $53 |
| GENZYME CORPORATION | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: OPZELURA, ADBRY, SKYRIZI, COSENTYX, TALTZ, CIBINQO, NEMLUVIO, DUPIXENT.
Industry payments across OK — which companies pay providers there.
